Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Regulation of encephalitogenicity of neuroantigen-primed T cells by nitric oxide: Implications for multiple sclerosis.
Inpatient Rehabilitation Utilization for Medicare Beneficiaries with Multiple Sclerosis.
Modelling and Prediction of 25-Hydroxyvitamin D Levels in Norwegian Relapsing-Remitting Multiple Sclerosis Patients.
Electroacupuncture Promotes the Differentiation of Transplanted Bone Marrow Mesenchymal Stem Cells Pre-Induced with Neurotrophin-3 and Retinoic Acid into Oligodendrocyte-Like Cells in Demyelinated Spinal Cord of Rats.
Multiple sclerosis: An old drug plays a new trick.
Is natalizumab overshooting its rebound?
RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells.
Efficacy and safety of alemtuzumab in patients with relapsing-remitting multiple sclerosis who relapsed on prior therapy: Four-year follow-up of the Care-MS II study.
Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses.
Synthesis of 5α-cholestan-6-one derivatives and their inhibitory activities of NO production in activated microglia: Discovery of a novel neuroinflammation inhibitor.
Central Nervous System and its Disease Models on a Chip.
TRPM4 cation channel mediates axonal and neuronal degeneration in experimental autoimmune encephalomyelitis and multiple sclerosis.
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes.
Distribution of JC polyomavirus genotypes in Tunisian renal transplant recipients between January 2008 and January 2011.
Ongoing Oxidative Stress Causes Subclinical Neuronal Dysfunction in the Recovery Phase of EAE.
Very early MS -- insights from MRI.
Acorda Announces Initiation of Phase 3 Clinical Trial for Dalfampridine in Post-Stroke Walking Deficits
Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients.
Medication withdrawal in relapsing-remitting multiple sclerosis: why not?
Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation.
Tangier's disease: An uncommon cause of facial weakness and non-length dependent demyelinating neuropathy.
Quantitative Evaluation of BAFF, HMGB1, TLR 4 AND TLR 7 Expression in Patients with Relapsing Remitting Multiple Sclerosis.
The best basic science paper in multiple sclerosis in 2014: Important role for the choroid plexus in the central nervous system entry of leukocytes.
Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720.
Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells.

Pages